Skaraborg Hospital
14
0
1
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 14 trials
100.0%
+13.5% vs industry average
36%
5 trials in Phase 3/4
0%
0 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Modified vs Standard CDED: Evaluation of a Nordic Adaptation of Nutritional Therapy in Paediatric Crohn's Disease
Role: collaborator
Bypass Equipoise Sleeve Trial (BEST)
Role: collaborator
Treatment of BV With First Deqularum and Then Direkt After Clindamycin
Role: lead
Losartan in Hypertensive Men and Women With Sleep Apnea Before and on Continuous Positive Airway Pressure (CPAP) Treatment
Role: lead
Bulkamid Treatment of Stress Incontinence in Women With Urinary Stress Incontinence and Not Suitable to TVT-procedure
Role: lead
Diagnosis of Bacterial Vaginosis Comparing Modified Hay/Ison With Molecular Diagnosis
Role: lead
Treatment of BV With Donaxyl and a Molecular Test of Cure
Role: lead
Will Lactobacillus Increase Cure Rate After Treatment of Bacterial Vaginosis and Chronic Vulvovaginal Candida
Role: lead
Continuous Positive Airway Pressure (CPAP) Treatment in Coronary Artery Disease and Sleep Apnea
Role: lead
A Randomized Controlled Mindfulness Based Stress Reduction Intervention in Women With Breast Cancer
Role: lead
Treatment of Bacterial Vaginosis in Early Pregnancy in Skaraborg and the Effect on Spontaneous Preterm Delivery
Role: lead
Treatment of Bacterial Vaginosis Combined With Human Lactobacilli
Role: lead
Individualized Duration of Peg-interferon/Ribavirin Treatment of Hepatitis C
Role: collaborator
Follow-up Pilot Study After a First Stroke
Role: lead
All 14 trials loaded